A carregar...
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review
Adult-onset Still's disease (AOSD) is often refractory to standard therapy. Anakinra (ANK), an interleukin-1 receptor antagonist, has demonstrated efficacy in single cases and small series of AOSD. We assessed the efficacy of ANK in a series of AOSD patients. Multicenter retrospective open-labe...
Na minha lista:
Publicado no: | Medicine (Baltimore) |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Wolters Kluwer Health
2015
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4616841/ https://ncbi.nlm.nih.gov/pubmed/26426623 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001554 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|